Featured Research

from universities, journals, and other organizations

Unreliable commercial lab kits may be hindering fight against cancer

Date:
October 4, 2013
Source:
American Association for Clinical Chemistry (AACC)
Summary:
A new study shows for the first time that low quality commercial lab kits may be one factor hampering the progress of cancer diagnostics.

Over the past 30 years, researchers have developed surprisingly few new tests for diagnosing cancer in spite of impressive advances in biomedical technology. A study appearing online today in Clinical Chemistry, the journal of AACC, shows for the first time that low quality commercial lab kits may be one factor hampering the progress of cancer diagnostics.

Related Articles


A doctor's ability to test for cancer in its earlier stages often determines a patient's chances of survival. Pancreatic ductal adenocarcinoma (PDAC) is a grim example of this. The majority of patients live only 3 to 18 months, because current diagnosis methods usually can't detect PDAC until it is too advanced to respond to treatment. Testing for the right biomarkers -- biological molecules whose presence indicates a condition or disease -- could be instrumental in the early detection of cancers like PDAC.

A team of researchers led by Eleftherios P. Diamandis, MD, PhD, of the University of Toronto, were hopeful they had found a new pancreatic cancer biomarker, the protein CUZD1, when they realized a faulty immunoassay kit had produced the data supporting CUZD1's viability. Using a kit marketed for CUZD1 detection, the team had successfully differentiated between pancreatic cancer and benign patient samples. Further analysis, however, revealed that the kit performed well because it actually detected the established tumor marker CA125. CUZD1 and CA125 share no molecular similarities that explain this error. This means that lax quality control during the manufacturing of the kit most likely caused this mix up.

Most investigators rely on commercial lab kits to evaluate the potential of candidate biomarkers. This study demonstrates, though, that costly risks counter the ease of using such kits. Diamandis's team lost 2 years, approximately $500,000, and thousands of valuable patient specimens, while also inadvertently raising false expectations about a potential breakthrough in PDAC testing because of the error in this lab kit.

"Reports like this one are relatively rare in the literature, since negative results are not usually published," said Diamandis. "However, these findings can contribute significantly to improving the quality of products intended for research purposes, and can save considerable research time and resources which would otherwise be wasted."

In this paper, the authors propose experiments to confirm the reliability of commercial lab kits. They hope this will help other researchers avoid similar problems, while also speeding up the development of much-needed effective cancer tests.

A podcast on this paper is available here: media.aacc.org/CCJPodcasts/ClinChem_201402_Prassas.mp3" href="http://media.aacc.org/CCJPodcasts/ClinChem_201402_Prassas.mp3">http://media.aacc.org/CCJPodcasts/ClinChem_201402_Prassas.mp3


Story Source:

The above story is based on materials provided by American Association for Clinical Chemistry (AACC). Note: Materials may be edited for content and length.


Journal Reference:

  1. I. Prassas, D. Brinc, S. Farkona, F. Leung, A. Dimitromanolakis, C. C. Chrystoja, R. Brand, V. Kulasingam, I. M. Blasutig, E. P. Diamandis. False Biomarker Discovery Due to Reactivity of a Commercial ELISA for CUZD1 with Cancer Antigen CA125. Clinical Chemistry, 2013; DOI: 10.1373/clinchem.2013.215236

Cite This Page:

American Association for Clinical Chemistry (AACC). "Unreliable commercial lab kits may be hindering fight against cancer." ScienceDaily. ScienceDaily, 4 October 2013. <www.sciencedaily.com/releases/2013/10/131004124935.htm>.
American Association for Clinical Chemistry (AACC). (2013, October 4). Unreliable commercial lab kits may be hindering fight against cancer. ScienceDaily. Retrieved January 31, 2015 from www.sciencedaily.com/releases/2013/10/131004124935.htm
American Association for Clinical Chemistry (AACC). "Unreliable commercial lab kits may be hindering fight against cancer." ScienceDaily. www.sciencedaily.com/releases/2013/10/131004124935.htm (accessed January 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, January 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC: Get Vaccinated for Measles

CDC: Get Vaccinated for Measles

Reuters - US Online Video (Jan. 30, 2015) The CDC is urging people to get vaccinated for measles amid an outbreak that began at Disneyland and has now infected more than 90 people. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Obama To Outline New Plan For Personalized Medicine

Obama To Outline New Plan For Personalized Medicine

Newsy (Jan. 30, 2015) President Obama is expected to speak with drugmakers Friday about his Precision Medicine Initiative first introduced last week. Video provided by Newsy
Powered by NewsLook.com
NFL Concussions Down; Still on Parents' Minds

NFL Concussions Down; Still on Parents' Minds

AP (Jan. 30, 2015) The NFL announced this week that the number of game concussions dropped by a quarter over last season. Still, the dangers of the sport still weigh on players, and parents&apos; minds. (Jan. 30) Video provided by AP
Powered by NewsLook.com
U.S. Wants to Analyze DNA from 1 Million People

U.S. Wants to Analyze DNA from 1 Million People

Reuters - US Online Video (Jan. 30, 2015) The U.S. has proposed analyzing genetic information from more than 1 million American volunteers to learn how genetic variants affect health and disease. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins